| View |
|
DRP-15035
|
Tranexamic acid
|
Tracid
|
100 mg/mL (500 mg/5 mL)
|
Solution for Injection (IV)
|
Antifibrinolytic
|
Swiss Parenterals Ltd. (Block-B)
|
India
|
Initial
|
22 March 2024
|
22 March 2029
|
| View |
|
DR-XY49024
|
Topotecan (as hydrochloride)
|
Toponova
|
4mg
|
Powder for Concentrate Solution for Infusion
|
Antineoplastic Agent [Topoisomerase 1 (TOP1)
Inhibitor]
|
Venus Remedies, Limited.
|
India
|
Initial
|
22 March 2024
|
22 March 2029
|
| View |
|
DRHR-2352
|
Ethyl Alcohol
|
Perfect Defense
|
70 mg/100 mg (70% v/v)
|
Solution (Mellow Green
Scent)
|
Antiseptic/Disinfectant
|
Zelwalk Enterprises
|
Philippines
|
Initial
|
22 March 2024
|
22 March 2029
|
| View |
|
DRP-5973-05
|
Docetaxel (as trihydrate)
|
Doxetacent
|
80 mg / 2 mL
|
Concentrate Solution for I.V. Infusion
|
Antineoplastic (Taxane)
|
Getwell Pharmaceuticals
|
India
|
Renewal
|
28 April 2024
|
28 January 2030
|
| View |
|
DRP-11724-01
|
Ciprofloxacin (as Hydrochloride)
|
Cirok
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Fluoroquinolone)
|
Ratnatris Pharmaceuticals Pvt. Ltd
|
India
|
CLIDP Conversion
|
05 May 2023
|
25 April 2027
|
| View |
|
DRP-10710-03
|
Piperacillin (As Sodium) + Tazobactam (As Sodium)
|
Rytam
|
4g/500mg
|
Powder for Injection (IV)
|
Antibacterial (Penicillin/Beta-lactamase inhibitor)
|
Reyoung Pharmaceutical Co. Ltd
|
China
|
CLIDP Conversion
|
07 April 2023
|
01 December 2026
|
| View |
|
BRP-039-01
|
Heparin Sodium
|
Hemolate
|
5000 IU/ mL (25000 IU/mL)
|
Solution for Injection (IV/SC)
|
Anticoagulant
|
Troikaa Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
10 March 2024
|
02 January 2027
|
| View |
|
BRP-090-01
|
Equine Anti-rabies Immunoglobulin
|
Zenuine
|
200 IU/mL (1,000 IU/5 mL)
|
Solution for Injection (IM)
|
Immunoglobulins
|
Vins Bioproducts, Ltd.
|
India
|
Renewal
|
05 April 2024
|
16 March 2029
|
| View |
|
DR-XY437888
|
Valsartan
|
Valvex 80
|
80 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
WEST-COAST PHARMACEUTICAL WORKS LTD
|
India
|
Renewal
|
12 March 2024
|
09 October 2029
|
| View |
|
DRHR-1969
|
Ethyl Alcohol
|
Casino – Active
|
70% (v/v)
|
Solution
|
Antiseptic / Disinfectant
|
International Pharmaceuticals, Inc.
|
Philippines
|
Renewal
|
25 March 2024
|
22 July 2029
|
| View |
|
DRP-10076-01
|
Lansoprazole
|
Lansoquest
|
30 mg
|
Delayed Release Capsule
|
Proton Pump Inhibitor
|
Friends Pharma (Pvt.) Ltd
|
Pakistan
|
Renewal
|
24 March 2024
|
28 April 2026
|
| View |
|
DRP-10455-01
|
Paracetamol + Thiamine Hydrochloride (Vitamin B1) + Pyridoxine Hydrochloride (Vitamin B6) + Cyanocobalamin (Vitamin B12)
|
None
|
500 mg / 50 mg / 100 mg / 100 mcg /
|
Film-Coated Tablet
|
Analgesic/ Antipyretic/ Vitamins
|
Sapphire Lifesciences Pvt. Ltd
|
India
|
Renewal
|
26 March 2024
|
01 October 2026
|
| View |
|
DRP-10525-02
|
Cefoperazone (as sodium) + Sulbactam (as sodium)
|
Winpersul
|
1 g / 500 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Inject Care Parenterals Pvt. Ltd
|
India
|
CLIDP Conversion
|
13 March 2024
|
11 October 2026
|
| View |
|
DRP-10530-05
|
Linezolid
|
None
|
2mg/mL (600mg/300mL)
|
Solution for Injection for I.V. Infusion
|
'-'
|
Ahlcon Parenterals (India) Limited
|
India
|
CLIDP Conversion
|
28 March 2024
|
12 October 2026
|
| View |
|
DRP-10631-10
|
Vancomycin (as hydrochloride)
|
Vancomef 1000
|
1 g
|
Powder for Injection (IV)
|
Antibacterial (Glycopeptide)
|
Venus Remedies, Limited
|
India
|
CLIDP Conversion
|
17 March 2024
|
10 November 2026
|
| View |
|
DRP-10689-01
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Rontaz 4.5g
|
4 g/500 mg
|
Powder for Injection for I.V. Infusion
|
Antibacterial (Penicillin/Beta-lactamase Inhibitor)
|
North China Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
28 March 2024
|
08 November 2026
|
| View |
|
DRP-10877-04
|
Sevelamer Carbonate
|
Zevlar
|
800 mg
|
Film-Coated Tablet
|
Phosphate Binder
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
17 March 2024
|
10 December 2026
|
| View |
|
DRP-10878-05
|
Clopidogrel (as bisulfate)
|
Congrel
|
75 mg
|
Film-Coated Tablet
|
Antithrombotic Agent (Platelet Aggregation Inhibitor)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 March 2024
|
10 November 2026
|
| View |
|
DRP-10878-06
|
Clopidogrel (as bisulfate)
|
Clotimax
|
75 mg
|
Film-Coated Tablet
|
Antithrombotic Agent (Platelet Aggregation Inhibitor)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
25 March 2024
|
10 December 2026
|
| View |
|
DRP-10946-03
|
Gentamicin (as sulfate)
|
Gentalyf
|
3mg/mL (0.3% w/v)
|
Ophthalmic/Otic Solution (Drops)
|
Antibacterial (Aminoglycoside)
|
Egyptian International Pharmaceutical Industries Co. (EIPICO)
|
Egypt
|
CLIDP Conversion
|
24 March 2024
|
21 December 2026
|